You have a fair point. Still, if S Mutans was nullified, I do believe this will significantly impact dental practice cash flow that I wouldn't be surprised if most goes out of business (over a long timeframe, as more people get this treatment).
If your practice has margins of 20%, then a 25% drop in procedures will mean you go out of business.
And why hasn't anyone started selling this? Well, large-scale synthesis and reproduction of genetically modified bacteria has significant upfront costs; no one is going to invest $20m in a production line if all they can do is sell it on darknet markets.